Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury. 2022

Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Recently, cytokines belonging to C1q/tumour necrosis factor-related proteins (CTRPs) superfamily have attracted increasing attention due to multiple metabolic functions and desirable anti-inflammatory effects. These various molecular effectors exhibit key roles upon the onset of cardiovascular diseases, making them novel adipo/cardiokines. This review article aimed to highlight recent findings correlated with therapeutic effects and additional mechanisms specific to the CTRP9, particularly in cardiac ischaemia/reperfusion injury (IRI). Besides, the network of the CTPR9 signalling pathway and its possible relationship with IRI were discussed. Together, the discovery of all involved underlying mechanisms could shed light to alleviate the pathological sequelae after the occurrence of IRI.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
June 2019, Cardiovascular research,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
October 2006, Biochemical and biophysical research communications,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
April 2022, Journal of cellular and molecular medicine,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
January 2004, Current pharmaceutical design,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
October 2019, International journal of experimental pathology,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
October 2011, European journal of heart failure,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
May 1994, The British journal of surgery,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
November 2017, Journal of cellular and molecular medicine,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
October 2023, Cardiovascular research,
Seyyed-Reza Sadat-Ebrahimi, and Hassan Amini, and Reza Rahbarghazi, and Paria Habibollahi, and Shahrouz Ghaderi, and Hadi Rajabi, and Aysa Rezabakhsh
June 2019, Cardiovascular research,
Copied contents to your clipboard!